Osr Holdings Inc (OSRH)

$0.62 -0.03 (-3.97%)
Market Cap 18.81M
Revenue (ttm) 2.91M
Net Income (ttm) -27.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -929.90%
Debt to Equity Ratio 0.03
Volume 1,917,554
Avg Vol 7,723,614
Day's Range N/A - N/A
Shares Out 33.13M
Stochastic %K 39%
Beta 0.86
Analysts Strong Buy
Price Target N/A

Company Profile

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 635 7700
Address:
10900 NE 4th Street, Suite 2300, Bellevue, United States
Genesys01
Genesys01 May. 13 at 9:31 PM
$OSRH not correct, there are still 1 million shares available for borrowing. Today they borrowed 200k shares for shorting, which is 10% of the volume.
0 · Reply
uptrend2025
uptrend2025 May. 13 at 9:28 PM
$OSRH Dip and rip tomorrow?
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 8:55 PM
$OSRH agreed, clear accumulation in Progress Got to feed those who will feed us !
0 · Reply
IldijanaMM
IldijanaMM May. 13 at 8:44 PM
$OSRH Patience won’t move until whales got what they want in shares!
0 · Reply
hitlist0
hitlist0 May. 13 at 8:23 PM
$OSRH this has legit news and stocks like YMAT & DXF runs from .50c to 1$ with no news 🙄🤯
0 · Reply
SittinDuck
SittinDuck May. 13 at 7:53 PM
$OSRH I think we can all agree the new low is .60. I’m done with a steady climb but as a penny stock it makes you wonder how long it’ll last.
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 7:39 PM
$OSRH You simply don’t put out a PR like this 👇 without a solid plan … common sense 101 https://www.accessnewswire.com/newsroom/en/biotechnology/ceo-statement-to-shareholders-1166123
1 · Reply
I_H8_SHORTS
I_H8_SHORTS May. 13 at 7:34 PM
$OSRH geez.. I hope we don’t get another billion dollar contract (Samsung). The share price would probably drop to .25. This makes no sense. The market doesn’t believe the companys pr’s I guess.
2 · Reply
eatsleeptrades
eatsleeptrades May. 13 at 7:32 PM
$OSRH no shares available to short…..
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 7:31 PM
$OSRH fliptards have left the building Investors are taking over 👇
0 · Reply
Latest News on OSRH
OSR Holdings CEO says company not pursuing reverse stock split

2026-05-12T19:35:00.000Z - 1 day ago

OSR Holdings CEO says company not pursuing reverse stock split

CEO Statement to Shareholders

May 12, 2026, 9:16 AM EDT - 1 day ago

CEO Statement to Shareholders

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

May 5, 2026, 1:05 PM EDT - 8 days ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

Apr 30, 2026, 9:15 AM EDT - 13 days ago

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

OSR Holdings enters $815M global license agreement for VXM01 with BCM Europe

2026-04-29T16:28:46.000Z - 14 days ago

OSR Holdings enters $815M global license agreement for VXM01 with BCM Europe

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

Apr 29, 2026, 9:50 AM EDT - 14 days ago

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

OSR Holdings eliminates $2.02M warrant overhang

2026-04-09T13:34:34.000Z - 4 weeks ago

OSR Holdings eliminates $2.02M warrant overhang

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

Apr 9, 2026, 9:15 AM EDT - 4 weeks ago

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Mar 30, 2026, 9:00 AM EDT - 6 weeks ago

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Mar 27, 2026, 9:00 AM EDT - 6 weeks ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings announces update to $815M VXM01 licensing deal structure

2026-03-23T12:46:05.000Z - 7 weeks ago

OSR Holdings announces update to $815M VXM01 licensing deal structure

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

Mar 23, 2026, 8:30 AM EDT - 7 weeks ago

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

OSR Holdings subsidiary signs NDA with Sinopharm

2026-03-19T13:07:19.000Z - 7 weeks ago

OSR Holdings subsidiary signs NDA with Sinopharm

OSR Holdings subsidiary signs NDA with Sinopharm

2026-03-19T13:07:07.000Z - 7 weeks ago

OSR Holdings subsidiary signs NDA with Sinopharm

Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities

Mar 19, 2026, 8:55 AM EDT - 7 weeks ago

Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities

OSR Holdings granted 180-day Nasdaq extension

2026-03-05T14:44:08.000Z - 2 months ago

OSR Holdings granted 180-day Nasdaq extension

OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum

Mar 5, 2026, 9:30 AM EST - 2 months ago

OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum

OSR Holdings CEO says fundamentals of business ‘remain strong’

2026-02-02T14:55:28.000Z - 3 months ago

OSR Holdings CEO says fundamentals of business ‘remain strong’

OSR Holdings completes Woori IO acquisition

2026-01-27T13:50:45.000Z - 3 months ago

OSR Holdings completes Woori IO acquisition

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

Jan 27, 2026, 8:30 AM EST - 3 months ago

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Jan 22, 2026, 9:55 AM EST - 3 months ago

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Jan 16, 2026, 9:20 AM EST - 4 months ago

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Jan 12, 2026, 8:05 AM EST - 4 months ago

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

OSR Holdings announces Woori IO shareholders approve share exchange

2025-12-19T16:55:10.000Z - 5 months ago

OSR Holdings announces Woori IO shareholders approve share exchange

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Dec 19, 2025, 11:50 AM EST - 5 months ago

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Dec 4, 2025, 3:19 PM EST - 5 months ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Vaximm updates term sheet with BCM Europe to shorten exclusivity period

2025-12-02T15:06:23.000Z - 5 months ago

Vaximm updates term sheet with BCM Europe to shorten exclusivity period

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Dec 2, 2025, 9:53 AM EST - 5 months ago

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

Dec 1, 2025, 3:01 PM EST - 5 months ago

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

OSR Holdings’ Vaximm AG enters non-binding term sheet with BCM Europe

2025-11-21T14:25:17.000Z - 6 months ago

OSR Holdings’ Vaximm AG enters non-binding term sheet with BCM Europe

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

Nov 21, 2025, 9:20 AM EST - 6 months ago

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

Nov 14, 2025, 11:10 AM EST - 6 months ago

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

OSR Holdings’ glucose monitor demonstrates accuracy and precision in pilot study

2025-11-06T13:48:10.000Z - 6 months ago

OSR Holdings’ glucose monitor demonstrates accuracy and precision in pilot study

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Nov 6, 2025, 8:30 AM EST - 6 months ago

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

Oct 20, 2025, 11:39 AM EDT - 7 months ago

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

OSR Holdings to acquire Woori IO for needle-free glucose monitoring

2025-10-14T12:41:26.000Z - 7 months ago

OSR Holdings to acquire Woori IO for needle-free glucose monitoring

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

Oct 14, 2025, 8:30 AM EDT - 7 months ago

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

OSR Holdings receives non-compliance letter from Nasdaq

2025-09-09T21:35:11.000Z - 8 months ago

OSR Holdings receives non-compliance letter from Nasdaq

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

Sep 9, 2025, 5:30 PM EDT - 8 months ago

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Aug 1, 2025, 1:29 PM EDT - 10 months ago

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

OSR Holdings Provides Transparency Update on Equity Financing Instruments

Jul 31, 2025, 12:45 PM EDT - 10 months ago

OSR Holdings Provides Transparency Update on Equity Financing Instruments

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

Jul 30, 2025, 4:10 PM EDT - 10 months ago

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

OSR Holdings to acquire glucose monitoring provider Woori IO

2025-07-24T11:41:06.000Z - 10 months ago

OSR Holdings to acquire glucose monitoring provider Woori IO

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

Jul 24, 2025, 7:30 AM EDT - 10 months ago

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

Jul 15, 2025, 7:30 AM EDT - 10 months ago

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

OSR Holdings announces strategic roadmap for tokenization

2025-07-09T12:05:08.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

Jul 9, 2025, 7:58 AM EDT - 11 months ago

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

OSR Holdings announces strategic roadmap for tokenization

2025-07-08T14:16:29.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

OSR Holdings announces strategic roadmap for tokenization

2025-07-08T14:10:12.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

OSR Holdings files to sell 15.41M shares of common stock for holders

2025-05-28T21:30:31.000Z - 1 year ago

OSR Holdings files to sell 15.41M shares of common stock for holders

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

May 22, 2025, 7:36 AM EDT - 1 year ago

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

May 2, 2025, 7:30 AM EDT - 1 year ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

Apr 9, 2025, 7:54 AM EDT - 1 year ago

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Apr 3, 2025, 7:30 AM EDT - 1 year ago

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Mar 26, 2025, 7:16 AM EDT - 1 year ago

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Mar 25, 2025, 7:00 AM EDT - 1 year ago

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

Feb 14, 2025, 6:10 PM EST - 1 year ago

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

Genesys01
Genesys01 May. 13 at 9:31 PM
$OSRH not correct, there are still 1 million shares available for borrowing. Today they borrowed 200k shares for shorting, which is 10% of the volume.
0 · Reply
uptrend2025
uptrend2025 May. 13 at 9:28 PM
$OSRH Dip and rip tomorrow?
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 8:55 PM
$OSRH agreed, clear accumulation in Progress Got to feed those who will feed us !
0 · Reply
IldijanaMM
IldijanaMM May. 13 at 8:44 PM
$OSRH Patience won’t move until whales got what they want in shares!
0 · Reply
hitlist0
hitlist0 May. 13 at 8:23 PM
$OSRH this has legit news and stocks like YMAT & DXF runs from .50c to 1$ with no news 🙄🤯
0 · Reply
SittinDuck
SittinDuck May. 13 at 7:53 PM
$OSRH I think we can all agree the new low is .60. I’m done with a steady climb but as a penny stock it makes you wonder how long it’ll last.
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 7:39 PM
$OSRH You simply don’t put out a PR like this 👇 without a solid plan … common sense 101 https://www.accessnewswire.com/newsroom/en/biotechnology/ceo-statement-to-shareholders-1166123
1 · Reply
I_H8_SHORTS
I_H8_SHORTS May. 13 at 7:34 PM
$OSRH geez.. I hope we don’t get another billion dollar contract (Samsung). The share price would probably drop to .25. This makes no sense. The market doesn’t believe the companys pr’s I guess.
2 · Reply
eatsleeptrades
eatsleeptrades May. 13 at 7:32 PM
$OSRH no shares available to short…..
0 · Reply
KeepItRealistic
KeepItRealistic May. 13 at 7:31 PM
$OSRH fliptards have left the building Investors are taking over 👇
0 · Reply
TCLutz
TCLutz May. 13 at 7:28 PM
$AEHL —> $OSRH IS MY NEXT PLAY!! Should boom ~ June 18 🔥💀🔥 💪🫡🔥
0 · Reply
KingEdward
KingEdward May. 13 at 7:18 PM
$OSRH You need to start moving healthily like $MBAI and $SRXH I alerted this group sometime back to get in early.
0 · Reply
Sparky5470
Sparky5470 May. 13 at 6:56 PM
$OSRH I’ll buy if you buy
0 · Reply
Wtfyw76
Wtfyw76 May. 13 at 6:43 PM
$OSRH algos down, low volume
0 · Reply
eatsleeptrades
eatsleeptrades May. 13 at 6:38 PM
$QUCY target hit here. Putting it all into $OSRH $TDIC $FCHL
0 · Reply
TCLutz
TCLutz May. 13 at 6:20 PM
$OSRH This is what I like to call getting in early! Grab your seats folks! The show starts in a week or two!! 💪🫡🔥
0 · Reply
Tim442
Tim442 May. 13 at 6:20 PM
$OSRH accumulation on the tape by the looks of activity today constant churn out of the last weak holders. Ready for the .70's disco era.
0 · Reply
TCLutz
TCLutz May. 13 at 5:57 PM
$OSRH Adding! 🫡💪🔥
0 · Reply
ic32
ic32 May. 13 at 5:54 PM
$OSRH before that 200 million volume day, our average volume was below 1 million. Now everyday has been gaining in volume steadily 😊
1 · Reply
hitlist0
hitlist0 May. 13 at 5:53 PM
$OSRH Powerhour let's close green
0 · Reply
Wtfyw76
Wtfyw76 May. 13 at 5:39 PM
$OSRH
0 · Reply
EssTradesEss
EssTradesEss May. 13 at 5:28 PM
$OSRH --> UP?
0 · Reply